Granulocyte colony-stimulating factor-induced hypersensitivity reaction with leukocytosis in a pediatric germ cell tumor patient: a case report - Summary - MDSpire
Advertisement
Granulocyte colony-stimulating factor-induced hypersensitivity reaction with leukocytosis in a pediatric germ cell tumor patient: a case report
To report a case of systemic hypersensitivity reaction and leukocytosis in a pediatric patient following administration of different G-CSF formulations after chemotherapy, highlighting the clinical significance of these findings.
Key Findings:
The patient experienced severe hypotension and hypoxemia within hours of G-CSF administration, indicating a serious adverse reaction.
Leukocytosis was noted, with a significant increase in white blood cell count, raising concerns about the safety of G-CSF formulations.
Eosinophilia suggested drug sensitization, emphasizing the need for careful monitoring.
Interpretation:
This case highlights the potential for hypersensitivity reactions to G-CSF, even with different formulations, and underscores the need for clinical vigilance in pediatric patients receiving G-CSF.
Limitations:
The case is singular and may not represent broader patient populations, necessitating further studies.
Further studies are needed to validate the safety profile of efbemalenograstim alfa-vuxw in pediatric patients, particularly in diverse populations.
Conclusion:
This is the first documented pediatric case of recurrent systemic hypersensitivity reactions induced by sequential administration of different G-CSF formulations, underscoring the importance of monitoring for hypersensitivity in pediatric patients.
